Schonfeld Strategic Advisors’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.75M | Buy |
752,984
+140,765
| +23% | +$1.26M | 0.05% | 414 |
|
|
2025
Q1 | $4.59M | Buy |
612,219
+394,479
| +181% | +$2.96M | 0.03% | 490 |
|
|
2024
Q4 | $1.64M | Buy |
217,740
+46,650
| +27% | +$351K | 0.01% | 855 |
|
|
2024
Q3 | $1.3M | Sell |
171,090
-281,513
| -62% | -$2.14M | 0.01% | 939 |
|
|
2024
Q2 | $2.8M | Buy |
+452,603
| New | +$2.8M | 0.02% | 656 |
|
|
2023
Q3 | – | Sell |
-121,137
| Closed | -$853K | – | 1636 |
|
|
2023
Q2 | $853K | Buy |
+121,137
| New | +$853K | 0.01% | 1014 |
|
|
2023
Q1 | – | Sell |
-21,100
| Closed | -$242K | – | 2020 |
|
|
2022
Q4 | $242K | Sell |
21,100
-186,872
| -90% | -$2.15M | ﹤0.01% | 1874 |
|
|
2022
Q3 | $2.62M | Buy |
207,972
+36,676
| +21% | +$462K | 0.02% | 755 |
|
|
2022
Q2 | $1.81M | Sell |
171,296
-116,404
| -40% | -$1.23M | 0.02% | 721 |
|
|
2022
Q1 | $4.68M | Buy |
287,700
+234,500
| +441% | +$3.81M | 0.04% | 426 |
|
|
2021
Q4 | $737K | Buy |
53,200
+23,741
| +81% | +$329K | 0.01% | 1018 |
|
|
2021
Q3 | $423K | Sell |
29,459
-75,628
| -72% | -$1.09M | ﹤0.01% | 1276 |
|
|
2021
Q2 | $1.66M | Buy |
105,087
+85,383
| +433% | +$1.35M | 0.02% | 739 |
|
|
2021
Q1 | $201K | Sell |
19,704
-67,687
| -77% | -$690K | ﹤0.01% | 1463 |
|
|
2020
Q4 | $650K | Sell |
87,391
-154,020
| -64% | -$1.15M | 0.01% | 918 |
|
|
2020
Q3 | $830K | Buy |
241,411
+74,183
| +44% | +$255K | 0.02% | 715 |
|
|
2020
Q2 | $797K | Buy |
+167,228
| New | +$797K | 0.02% | 633 |
|
|
2020
Q1 | – | Sell |
-397,266
| Closed | -$1.37M | – | 1152 |
|
|
2019
Q4 | $1.37M | Sell |
397,266
-514,034
| -56% | -$1.77M | 0.03% | 419 |
|
|
2019
Q3 | $2.61M | Sell |
911,300
-1,322,400
| -59% | -$3.79M | 0.08% | 265 |
|
|
2019
Q2 | $8.47M | Buy |
+2,233,700
| New | +$8.47M | 0.3% | 83 |
|
|
2019
Q1 | – | Sell |
-11,000
| Closed | -$89K | – | 1026 |
|
|
2018
Q4 | $89K | Sell |
11,000
-43,800
| -80% | -$354K | ﹤0.01% | 1009 |
|
|
2018
Q3 | $418K | Buy |
+54,800
| New | +$418K | 0.02% | 609 |
|
|
2017
Q3 | – | Sell |
-13,723
| Closed | -$76K | – | 574 |
|
|
2017
Q2 | $76K | Sell |
13,723
-62,860
| -82% | -$348K | 0.01% | 569 |
|
|
2017
Q1 | $643K | Buy |
+76,583
| New | +$643K | 0.06% | 327 |
|